Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
7.46M
-
Number of holders
-
17
-
Total 13F shares, excl. options
-
542K
-
Shares change
-
+80K
-
Total reported value, excl. options
-
$4.29M
-
Value change
-
+$627K
-
Number of buys
-
6
-
Number of sells
-
-4
-
Price
-
$7.97
Significant Holders of KALA BIO, Inc. - Common Stock, $0.001 par value per share (KALA) as of Q1 2024
17 filings reported holding KALA - KALA BIO, Inc. - Common Stock, $0.001 par value per share as of Q1 2024.
KALA BIO, Inc. - Common Stock, $0.001 par value per share (KALA) has 17 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 542K shares
of 7.46M outstanding shares and own 7.28% of the company stock.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (267K shares), MILLENNIUM MANAGEMENT LLC (133K shares), OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) (72.6K shares), Board of Trustees of The Leland Stanford Junior University (21.1K shares), GEODE CAPITAL MANAGEMENT, LLC (18.2K shares), CITADEL ADVISORS LLC (13.5K shares), RENAISSANCE TECHNOLOGIES LLC (11.4K shares), UBS Group AG (2.18K shares), Tower Research Capital LLC (TRC) (1.62K shares), and MORGAN STANLEY (1.36K shares).
This table shows the top 17 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.